ATE524732T1 - Wirkstoffresistenz gegen pflanzenalkaloide basieren auf dem myd88-status in einer zelle und verfahren zum hemmen der signalgebung durch den tlr-4:myd88-signalweg - Google Patents

Wirkstoffresistenz gegen pflanzenalkaloide basieren auf dem myd88-status in einer zelle und verfahren zum hemmen der signalgebung durch den tlr-4:myd88-signalweg

Info

Publication number
ATE524732T1
ATE524732T1 AT07751467T AT07751467T ATE524732T1 AT E524732 T1 ATE524732 T1 AT E524732T1 AT 07751467 T AT07751467 T AT 07751467T AT 07751467 T AT07751467 T AT 07751467T AT E524732 T1 ATE524732 T1 AT E524732T1
Authority
AT
Austria
Prior art keywords
myd88
plant alkaloids
signaling
tlr
status
Prior art date
Application number
AT07751467T
Other languages
English (en)
Inventor
Gil Mor
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Application granted granted Critical
Publication of ATE524732T1 publication Critical patent/ATE524732T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07751467T 2006-02-23 2007-02-23 Wirkstoffresistenz gegen pflanzenalkaloide basieren auf dem myd88-status in einer zelle und verfahren zum hemmen der signalgebung durch den tlr-4:myd88-signalweg ATE524732T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77630406P 2006-02-23 2006-02-23
US78816806P 2006-03-31 2006-03-31
PCT/US2007/004707 WO2007100650A2 (en) 2006-02-23 2007-02-23 Drug resistance to plant alkaloids based upon myd88 status in a cell and methods of inhibiting signaling through the tlr-4:myd88 pathway

Publications (1)

Publication Number Publication Date
ATE524732T1 true ATE524732T1 (de) 2011-09-15

Family

ID=38349578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07751467T ATE524732T1 (de) 2006-02-23 2007-02-23 Wirkstoffresistenz gegen pflanzenalkaloide basieren auf dem myd88-status in einer zelle und verfahren zum hemmen der signalgebung durch den tlr-4:myd88-signalweg

Country Status (4)

Country Link
US (1) US7985538B2 (de)
EP (1) EP1996935B1 (de)
AT (1) ATE524732T1 (de)
WO (1) WO2007100650A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606096D0 (en) * 2006-03-27 2006-05-03 Cbmm Sa Screening method
WO2010020590A1 (en) * 2008-08-20 2010-02-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the response to anti-cancer treatment with an agonist of tlr7 or an agonist of tlr8
EP2432872B1 (de) * 2009-05-22 2015-09-30 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Akt-phosphorylierung an ser473 als indikator für chemotherapie auf der basis von taxan
SG10201503402XA (en) 2010-01-27 2015-06-29 Takeda Pharmaceutical Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
WO2019055597A1 (en) * 2017-09-13 2019-03-21 National Tuberous Sclerosis Association, Inc. Methods and compositions for the treatment of tsc
CN111643677B (zh) * 2020-05-26 2023-06-27 四川省肿瘤医院 一种包封TLR4/MyD88信号通路拮抗剂的纳米脂质体及其制备方法和应用
CN115715802A (zh) * 2022-09-09 2023-02-28 上海市普陀区中心医院 MyD88抑制剂在制备治疗乳腺癌和逆转乳腺癌紫杉醇耐药的药物中的应用
CN117418013A (zh) * 2023-12-19 2024-01-19 四川省肿瘤医院 用于检测卵巢癌细胞MyD88基因5'URR CpG岛甲基化水平的引物、方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1697718A4 (de) 2003-11-26 2007-11-28 Univ Yale Auf apoptose beruhende bewertung der chemosensitivität bei krebspatienten
EA200801045A1 (ru) 2005-10-12 2008-10-30 Кэнсер Рисерч Текнолоджи Лтд. Способы и композиции для лечения иммунных нарушений

Also Published As

Publication number Publication date
EP1996935B1 (de) 2011-09-14
WO2007100650A3 (en) 2008-04-03
US7985538B2 (en) 2011-07-26
WO2007100650A2 (en) 2007-09-07
US20090220427A1 (en) 2009-09-03
EP1996935A2 (de) 2008-12-03

Similar Documents

Publication Publication Date Title
Hasanabady et al. ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer
Argyriou et al. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update
WO2007100650A3 (en) Drug resistance to plant alkaloids based upon myd88 status in a cell and methods of inhibiting signaling through the tlr-4:myd88 pathway
Oldenburg et al. Acetylcholine leads to free radical production dependent on KATP channels, Gi proteins, phosphatidylinositol 3-kinase and tyrosine kinase
DE602005025106D1 (de) Methoden zur medikamentenaufspürung auf der basis von in vitro differenzierten zellen
UA118649C2 (uk) ДВОЛАНЦЮГОВИЙ ЗАСІБ ДЛЯ PHKі ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ЕКСПРЕСІЇ ТРАНСТИРЕТИНУ (TTR)
WO2008006517A3 (en) Prediction of breast cancer response to taxane-based chemotherapy
ECSP088904A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
GB2467467C (en) TAZ/WWTR1 for diagnosis and treatment of cancer
EA201792650A1 (ru) ПРИМЕНЕНИЕ ЗАМЕЩЕННЫХ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНОВ ДЛЯ ЛЕЧЕНИЯ ЛИМФОМ
Pinto-Garcia et al. Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells
CY1116697T1 (el) Συνδετες sigma για την προληψη ή τη θεραπεια πονου που εχει προκληθει απο χημειοθεραπεια
WO2010135534A3 (en) Compositions for the treatment of metastatic cancer and methods of use thereof
RU2012154449A (ru) Катетер, допускающий различные дозировки активного агента
Luo et al. A narrative review of the antitumor studies of solanine
UY28861A1 (es) Nuevas combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
He et al. The aldehyde group of gossypol induces mitochondrial apoptosis via ROS-SIRT1-p53-PUMA pathway in male germline stem cell
EP1888089A4 (de) Ex-vivo-genexpression in vollblut als modell für die beurteilung von individueller variation gegenüber nahrungszusätzen
Koehler et al. Phenyltetrazolyl-phenylamides: Substituent impact on modulation capability and selectivity toward the efflux protein ABCG2 and investigation of interaction with the transporter
ATE504591T1 (de) Neue phosphorhaltige heterocyclische verbindungen,zuckeranaloga und zusammensetzungen mit antikrebswirkung, die diese enthalten
Kürten et al. Pre-treatment anemia in head and neck cancer: risk factors, subtypes, and survival outcomes
AR069639A1 (es) Composicion de nanoparticulas con superficie modificada
ATE499040T1 (de) Vorrichtung zur arzneimittelverabreichung und/oder überwachung des zustandes eines patienten
CL2011000366A1 (es) Método para administrar semillas, que comprende muestrear en forma no destructiva y evaluar el tejido de semillas individuales.
Song et al. Trinitrotoluene induces Endoplasmic reticulum stress and apoptosis in HePG2 cells

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties